Terremoto Biosciences

Terremoto | A seismic shift is coming to drug discovery and development

South San Francisco, United States · Founded 2021 · $358.0M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$358.0M
Last Round
$108.0M Series CJan 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Terremoto Biosciences is a clinical-stage biotechnology company pioneering lysine-targeted covalent chemistry to develop best-in-class and first-in-class small molecule medicines for oncology and genetic disease. Founded in 2021 and headquartered in South San Francisco, California, the company was co-founded by scientists from UCSF who helped create the emerging field of lysine-based covalency, enabling drug development against both established and previously undruggable targets. Terremoto's pipeline includes AKT1-selective inhibitors and other precision therapies, supported by leading investors including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital.

Summary

Terremoto Biosciences is a Biotech company based in South San Francisco, United States, founded in 2021. It has raised $358.0M in total across 3 rounds, most recently a $108.0M Series C round in Jan 2025. Investors include OrbiMed, Third Rock Ventures and RA Capital Management.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries C2025 (est.)
$108.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Terremoto Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/terremoto-biosciences"><img src="https://indexed.vc/api/badge/company/terremoto-biosciences" alt="Terremoto Biosciences on Indexed.vc" width="260" height="76" /></a>